FGF21 and chronic kidney disease: In general, FGF21 level was significantly increased in the CKD patients compared with the control (SMD = 0.97 (ng/L) 95% CI, 0.70–1.24 (ng/L)) with high heterogeneity (I2 = 85.5%, p < 0.001) (Figure 2).